MA56463A - Plate-forme d'administration non parentérale d'agent thérapeutique d'arthrospira platensis - Google Patents

Plate-forme d'administration non parentérale d'agent thérapeutique d'arthrospira platensis

Info

Publication number
MA56463A
MA56463A MA056463A MA56463A MA56463A MA 56463 A MA56463 A MA 56463A MA 056463 A MA056463 A MA 056463A MA 56463 A MA56463 A MA 56463A MA 56463 A MA56463 A MA 56463A
Authority
MA
Morocco
Prior art keywords
therapeutic agent
agent administration
administration platform
arthrospira platensis
parenteral therapeutic
Prior art date
Application number
MA056463A
Other languages
English (en)
Inventor
Mesfin Gewe
Benjamin Jester
James Roberts
Tracy Saveria
Michael Tasch
Original Assignee
Lumen Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lumen Bioscience Inc filed Critical Lumen Bioscience Inc
Publication of MA56463A publication Critical patent/MA56463A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/102—Coronaviridae (F)
    • C07K16/104—Severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/121—Helicobacter (G); Campylobacter (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1282—Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12—Unicellular algae; Culture media therefor
    • C12N1/125—Unicellular algae isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/517—Plant cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
MA056463A 2019-07-03 2020-07-02 Plate-forme d'administration non parentérale d'agent thérapeutique d'arthrospira platensis MA56463A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962870478P 2019-07-03 2019-07-03
US201962937995P 2019-11-20 2019-11-20
US201962943075P 2019-12-03 2019-12-03

Publications (1)

Publication Number Publication Date
MA56463A true MA56463A (fr) 2022-05-11

Family

ID=74100810

Family Applications (1)

Application Number Title Priority Date Filing Date
MA056463A MA56463A (fr) 2019-07-03 2020-07-02 Plate-forme d'administration non parentérale d'agent thérapeutique d'arthrospira platensis

Country Status (9)

Country Link
US (2) US12503682B2 (fr)
EP (1) EP3994152A4 (fr)
JP (2) JP7770675B2 (fr)
CN (1) CN114341165A (fr)
AU (1) AU2020298626A1 (fr)
CA (1) CA3143735A1 (fr)
IL (1) IL289420A (fr)
MA (1) MA56463A (fr)
WO (1) WO2021003456A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019222711A1 (fr) 2018-05-17 2019-11-21 Lumen Bioscience, Inc. Plate-forme d'administration de vaccin oral d'arthrospira platensis
US12252513B2 (en) 2018-07-16 2025-03-18 Lumen Bioscience, Inc. Thermostable phycobiliproteins produced from recombinant arthrospira
WO2020144164A1 (fr) 2019-01-07 2020-07-16 Bactolife Aps Protéines de liaison à des pathogènes
EP3994152A4 (fr) 2019-07-03 2023-08-02 Lumen Bioscience, Inc. Plate-forme d'administration non parentérale d'agent thérapeutique d'arthrospira platensis
EP4267185A4 (fr) * 2020-12-23 2024-10-30 Lumen Bioscience, Inc. Constructions comprenant des anticorps vhh à domaine unique dirigé contre le sars-cov-2
US20250136669A1 (en) * 2021-12-15 2025-05-01 Teikyo Heisei University Vhh antibody
AU2024272693A1 (en) * 2023-05-15 2025-11-20 Lumen Bioscience, Inc. Methanolytic agents and methods of using the same
EP4777835A1 (fr) * 2023-09-11 2026-07-22 ABSCI Corporation Procédés à haut rendement pour caractérisation cinétique, quantification et optimisation d'anticorps et d'expression de fragments d'anticorps dans des bactéries
CN117568180A (zh) * 2023-11-10 2024-02-20 浙江大学 一种载菌微藻、制备方法及其应用
WO2025125852A1 (fr) * 2023-12-11 2025-06-19 Abdali Nargess Vaccin oral contre la covid-19
US12466883B1 (en) 2024-05-13 2025-11-11 Lumen Bioscience, Inc. Leptin compositions and methods of making and using the same to support weight loss and/or maintenance
WO2026076425A1 (fr) 2024-10-04 2026-04-09 Biodrive, Inc. Plate-forme de bioadministration orale

Family Cites Families (194)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US4873192A (en) 1987-02-17 1989-10-10 The United States Of America As Represented By The Department Of Health And Human Services Process for site specific mutagenesis without phenotypic selection
FR2646438B1 (fr) 1989-03-20 2007-11-02 Pasteur Institut Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
JP2950888B2 (ja) 1989-04-21 1999-09-20 麒麟麦酒株式会社 カロチノイドの合成に有用なｄｎａ鎖
EP0393690B1 (fr) 1989-04-21 1995-03-29 Kirin Beer Kabushiki Kaisha Séquences de DNA utilisables dans la synthèse de caroténoides
US5429939A (en) 1989-04-21 1995-07-04 Kirin Beer Kabushiki Kaisha DNA sequences useful for the synthesis of carotenoids
US5684238A (en) 1990-03-02 1997-11-04 Amoco Corporation Biosynthesis of zeaxanthin and glycosylated zeaxanthin in genetically engineered hosts
JPH06253863A (ja) 1993-02-26 1994-09-13 Agency Of Ind Science & Technol スピルリナの形質転換方法およびスピルリナの形質転換体
US5661017A (en) 1993-09-14 1997-08-26 Dunahay; Terri Goodman Method to transform algae, materials therefor, and products produced thereby
AU702584B2 (en) 1993-12-27 1999-02-25 Kirin Holdings Kabushiki Kaisha DNA strands useful for the synthesis of xanthophylls and the process for producing the xanthophylls
DE69526842T3 (de) 1994-08-23 2005-10-27 Kirin Beer K.K. Ketogruppe-einführendes enzym, dafür kodierende dna und verfahren zur herstellung von ketocarotenoid
US6342389B1 (en) 1995-04-10 2002-01-29 Roger S. Cubicciotti Modified phycobilisomes and uses therefore
DK0747483T3 (da) 1995-06-09 2004-06-28 Dsm Ip Assets Bv Fermentativ carotenoid-produktion
ATE242812T1 (de) 1996-12-02 2003-06-15 Hoffmann La Roche Verbesserte fermentative herstellung von carotenoide
DE69837531T2 (de) 1997-02-19 2007-12-27 Enol Energy Inc., Naples Genetisch modifizierte cyanobakterien für die produktion von äthanol
CN1067719C (zh) 1997-07-10 2001-06-27 中山大学 外源基因转化螺旋藻的方法
JP3874897B2 (ja) 1997-08-07 2007-01-31 麒麟麦酒株式会社 β−カロチンハイドロキシラーゼ遺伝子およびその使用
JPH1156360A (ja) 1997-08-27 1999-03-02 Iwate Pref Gov エレクトロポレーションによる遺伝子導入法
JP3032841B2 (ja) 1997-12-02 2000-04-17 農林水産省果樹試験場長 β−カロテンハイドロキシラーゼ遺伝子
CA2330167A1 (fr) 1998-06-02 1999-12-09 University Of Maryland Genes de la biosynthese et du metabolisme du carotenoide et techniques d'utilisation
FR2784688B1 (fr) 1998-10-20 2002-12-13 Univ Grenoble 1 SEQUENCE D'ADNc DECRITE PAR SEQ ID N°1 TRANSCRIVANT UN ARNm CODANT POUR L'OXYDASE TERMINALE ASSOCIEE A LA BIOSYNTHESE DES CAROTENOIDES
BR0009510A (pt) 1999-04-01 2002-04-23 Basf Plant Science Gmbh Enzima, sequência de nucleotìdeos, construção de gene, vetor, organismo ou célula transgênica, processo para a produção de triacilglicerol, triacilgliceróis, e, uso de uma sequência de nucleotìdeos
US7157619B1 (en) 1999-08-30 2007-01-02 Monsanto Technology, L.L.C. Plant sterol acyltransferases
US6649376B1 (en) 1999-12-21 2003-11-18 The Regents Of The University Of California Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display
US7033806B2 (en) 2000-06-08 2006-04-25 The Regents Of The University Of California HY2 family of bilin reductases
US6818424B2 (en) 2000-09-01 2004-11-16 E. I. Du Pont De Nemours And Company Production of cyclic terpenoids
EP1360313A4 (fr) 2000-11-22 2004-08-04 Cargill Inc Biosynthese de carotenoides
US20040078846A1 (en) 2002-01-25 2004-04-22 Desouza Mervyn L. Carotenoid biosynthesis
US20050003474A1 (en) 2001-01-26 2005-01-06 Desouza Mervyn L. Carotenoid biosynthesis
WO2002097137A1 (fr) 2001-05-29 2002-12-05 The Regents Of The University Of California Expression genique commandee a l'aide de lumiere, faisant appel a des phytochromes heterologues
US7252964B2 (en) 2001-06-12 2007-08-07 Institut De Recherche Pour Le Developpement (I.R.D.) Isolated carotenoid biosynthesis gene cluster involved in canthaxanthin production and applications thereof
US20090215179A1 (en) 2001-07-20 2009-08-27 Transalgae Transgenically preventing establishment and spread of transgenic algae in natural ecosystems
US20030148319A1 (en) 2001-08-15 2003-08-07 Brzostowicz Patricia C. Genes encoding carotenoid compounds
US20040077068A1 (en) 2001-09-04 2004-04-22 Brzostowicz Patricia C. Carotenoid production from a single carbon substrate
US7396977B2 (en) 2001-10-23 2008-07-08 Japan Tobacco Inc. Method of elevating photosynthesis speed of plant by improving pyruvate phosphate dikinase
US7314974B2 (en) 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
AR038719A1 (es) 2002-03-01 2005-01-26 Monsanto Technology Llc Secuencia de adn de sintetasas bacterianas de esteres cerosos, proteinas y usos de las mismas
US7223909B2 (en) 2002-03-21 2007-05-29 Ball Horticultural 4-ketocarotenoids in flower petals
JP4415138B2 (ja) 2002-05-08 2010-02-17 独立行政法人産業技術総合研究所 義務教育、理科実験においても使用可能な大腸菌等への遺伝子導入手法
SE0201581D0 (sv) 2002-05-29 2002-05-29 Scandinavian Biotechnology Res New improved acyltransferase
US20060121468A1 (en) * 2002-06-26 2006-06-08 Allnutt F C T Viruses and virus-like particles for multiple antigen and target display
EP1532265A2 (fr) 2002-08-20 2005-05-25 Sungene GmbH & Co. KGaA Procede d'obtention de cetocarotinoides dans des organismes genetiquement modifies
AU2003258622A1 (en) 2002-08-20 2004-03-11 Sungene Gmbh And Co. Kgaa Method for the production of $g(b)-carotinoids
JP2006500055A (ja) 2002-09-27 2006-01-05 ディーエスエム アイピー アセッツ ビー．ブイ． ファフィア属によるゼアキサンチンの製造方法
WO2004029234A1 (fr) 2002-09-27 2004-04-08 Dsm Ip Assets B.V. Gene bhyd
US7232665B2 (en) 2002-12-19 2007-06-19 E. I. Du Pont De Nemours And Company Mutations affecting carotenoid production
US20040219629A1 (en) 2002-12-19 2004-11-04 Qiong Cheng Increasing carotenoid production in bacteria via chromosomal integration
US7291482B2 (en) 2002-12-20 2007-11-06 E.I. Du Pont De Nemours And Company Mutations affecting plasmid copy number
WO2004063358A1 (fr) 2003-01-09 2004-07-29 Basf Aktiengesellschaft Procedes de modification genetique d'organismes de l'espece blakeslea, organismes correspondants et leur utilisation
JP2006515516A (ja) 2003-01-09 2006-06-01 ビーエーエスエフ　アクチェンゲゼルシャフト 遺伝子改変されたＢｌａｋｅｓｌｅａ属の生物を使用する、カロチノイドまたはそれらの前駆体を製造するための方法、上記方法によって製造されたカロチノイドまたはそれらの前駆体、ならびにそれらの使用
DE10300649A1 (de) 2003-01-09 2004-07-22 Basf Ag Verfahren zur Herstellung von Ketocarotinoiden durch Kultivierung von genetisch veränderten Organismen
CN1826408B (zh) 2003-03-14 2011-01-26 塞托·帕尔斯科技公司 大容量离体电穿孔法
CA2521075A1 (fr) 2003-03-31 2004-10-14 Algentech Gene intervenant dans la biosynthese d'un carotenoide et micro-organisme marin, le paracoccus haeundaensis, produisant ce carotenoide
AP2005003409A0 (en) 2003-04-09 2005-12-31 Bayer Bioscience Nv Methods and means for increasing the tolerance of plants to stress conditions.
CN103131673A (zh) 2003-04-15 2013-06-05 巴斯福植物科学有限公司 编码非生物胁迫反应相关蛋白质的核酸序列，以及提高对环境胁迫耐性的植物和植物细胞
US7070952B2 (en) 2003-05-07 2006-07-04 E. I. Du Pont Nemours And Company Genes encoding carotenoid compounds
US7064196B2 (en) 2003-05-20 2006-06-20 E. I. Du Pont De Nemours And Company Genes encoding carotenoid compounds
US6929928B2 (en) 2003-06-12 2005-08-16 E. I. Du Pont De Nemours And Company Genes encoding carotenoid compounds
WO2005032597A1 (fr) 2003-09-29 2005-04-14 Nitto Denko Corporation Polyacetals biodegradables pour administration de polynucleotides in vivo
CN1528902A (zh) * 2003-10-02 2004-09-15 广东梅县梅雁蓝藻有限公司 用螺旋藻同源重组和表达人体基因的方法
ATE458809T1 (de) 2003-11-18 2010-03-15 Kirin Holdings Kk Neues carotenoidhydroxylasegen, verfahren zur herstellung von hydroxyliertem carotenoid und neues geranylgeranylpyrophosphatsynthasegen
US7232666B2 (en) 2003-12-03 2007-06-19 E. I. Du Pont De Nemours And Company Optimized bacterial host strains of Methylomonas sp. 16a
WO2005062867A2 (fr) 2003-12-19 2005-07-14 E.I. Dupont De Nemours And Company Nouvelles cetolases de carotenoide
WO2005062923A2 (fr) 2003-12-24 2005-07-14 Massachusetts Institute Of Technology Cibles geniques pour une meilleure production de carotenoides
US7741070B2 (en) 2003-12-24 2010-06-22 Massachusetts Institute Of Technology Gene targets for enhanced carotenoid production
FR2864968B1 (fr) 2004-01-09 2007-10-05 Inst Rech Developpement Ird Procede de production de carotenoides et bacteries mises en oeuvre
US20060041961A1 (en) 2004-03-25 2006-02-23 Abad Mark S Genes and uses for pant improvement
US7063957B2 (en) 2004-03-26 2006-06-20 The University Of Hong Kong Methods for production of astaxanthin from the green microalgae Chlorella in dark-heterotrophic cultures
EP1780281B1 (fr) 2004-06-04 2013-12-11 Kirin Holdings Kabushiki Kaisha Procédé de production de l'astaxanthine ou d'un produit métabolique de ce composé en utilisant les gènes de la caroténoïde cétolase et de la caroténoïde hydrolase
US7425625B2 (en) 2004-06-08 2008-09-16 E.I. Du Pont De Nemours And Company Carotenoid ketolase genes with improved ketocarotenoid yield
US20050281839A1 (en) * 2004-06-18 2005-12-22 Amha Belay Spirulina composition and antiallergic food
US7091031B2 (en) 2004-08-16 2006-08-15 E. I. Du Pont De Nemours And Company Carotenoid hydroxylase enzymes
JP2006075097A (ja) 2004-09-10 2006-03-23 Tadashi Matsunaga カロテノイド生産能を有する形質転換体及びカロテノイドの生産方法
NZ554386A (en) 2004-10-25 2009-12-24 Cytos Biotechnology Ag Gastric inhibtory polypeptide (GIP) antigen arrays with VLPs and uses thereof
US20060099710A1 (en) 2004-11-10 2006-05-11 Donnelly Mark I Vector for improved in vivo production of proteins
JP4799895B2 (ja) 2004-12-15 2011-10-26 電源開発株式会社 カロチノイド色素、スフィンゴ糖脂質、ユビキノンｑ−１０の生産方法
US20080148432A1 (en) 2005-12-21 2008-06-19 Mark Scott Abad Transgenic plants with enhanced agronomic traits
US7074604B1 (en) 2004-12-29 2006-07-11 E. I. Du Pont De Nemours And Company Bioproduction of astaxanthin using mutant carotenoid ketolase and carotenoid hydroxylase genes
RU2005101110A (ru) 2005-01-19 2006-06-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) (RU) Способ получения l-аминокислот с использованием бактерии семейства enterobacteriaceae, в которой разрушен путь биосинтеза гликогена
WO2006096392A2 (fr) 2005-03-04 2006-09-14 Diversa Corporation Enzymes intervenant dans les voies de synthese biologique d'astaxanthines, de carotenoides et d'isoprenoides, genes codant ces enzymes et procedes de production et d'utilisation de celles-ci
WO2006108226A1 (fr) * 2005-04-12 2006-10-19 The University Of Queensland Systeme de delivrance d’un vaccin
EP1928227A4 (fr) 2005-08-30 2009-05-20 Monsanto Technology Llc Plantes transgeniques a traits agronomiques ameliores
US7217537B2 (en) 2005-09-15 2007-05-15 E. I. Du Pont De Nemours And Company Method to increase carotenoid production in a microbial host cell by down-regulating glycogen synthase
WO2007035579A2 (fr) 2005-09-15 2007-03-29 The Regents Of The University Of California Procédés et compositions pour la production de gaz méthane
US20070065902A1 (en) 2005-09-19 2007-03-22 Dicosimo Deana J Process for chromosomal expression of foreign genes in the fliC region of a methylotrophic microbial host cell
US20070065900A1 (en) 2005-09-19 2007-03-22 Dicosimo Deana J Process for chromosomal expression of foreign genes in the cytochrome-C peroxidase (cytCP) region of a methylotrophic microbial host cell
US20070065903A1 (en) 2005-09-19 2007-03-22 Dicosimo Deana J Process for chromosomal expression of foreign genes in the hsdM region of a methylotrophic microbial host cell
US20070065901A1 (en) 2005-09-19 2007-03-22 Dicosimo Deana J Process for chromosomal expression of foreign genes in the PAPS reductase (cysH) region of a methylotrophic microbial host cell
EP2471919A1 (fr) 2005-10-28 2012-07-04 Tosoh Corporation Procédé de préparation de micro-organisme de synthèse de caroténoïde et procédé de production des caroténoïdes
KR100788479B1 (ko) 2005-11-25 2007-12-24 부경대학교 산학협력단 카로티노이드 생합성 유전자를 이용한 대장균으로부터아스타잔틴의 생산
GB0524873D0 (en) 2005-12-06 2006-01-11 New Royal Holloway & Bedford Bacterial production of carotenoids
CN101321859A (zh) 2005-12-06 2008-12-10 东曹株式会社 新微生物和使用该微生物生产类胡萝卜素的方法
US7393671B2 (en) 2006-03-30 2008-07-01 E.I. Du Pont De Nemours And Company Mutant carotenoid ketolases
US7422873B2 (en) 2006-03-31 2008-09-09 E.I. Du Pont De Nemours And Company Mutant carotenoid ketolase
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
CN1843150A (zh) * 2006-05-08 2006-10-11 陈晓雁 螺旋藻酶解生产工艺
AU2007254151A1 (en) 2006-05-19 2007-11-29 Ls9, Inc. Production of fatty acids and derivatives thereof
US8110670B2 (en) 2006-05-19 2012-02-07 Ls9, Inc. Enhanced production of fatty acid derivatives
WO2008021543A2 (fr) 2006-08-17 2008-02-21 Monsanto Technology, Llc Plantes transgéniques à caractères agronomiques renforcés
US20080107652A1 (en) 2006-08-25 2008-05-08 Science & Technology Corporation @ University Of New Mexico Stc.Unm Methods and compositions for control of disease in aquaculture
US20080124755A1 (en) 2006-10-12 2008-05-29 Michael Tai-Man Louie Biosynthesis of beta-cryptoxanthin in microbial hosts using an Arabidopsis thaliana beta-carotene hydroxylase gene
EP2087096A4 (fr) 2006-10-20 2009-11-25 Univ Arizona Cyanobacterie modifiee
KR100845582B1 (ko) 2006-11-09 2008-07-11 부경대학교 산학협력단 이소프레노이드와 카로티노이드 생합성 유전자로 형질전환된 대장균 및 이를 이용한 아스타잔틴의 대량 생산방법
US8846374B2 (en) 2006-12-12 2014-09-30 E I Du Pont De Nemours And Company Carotenoid production in a recombinant oleaginous yeast
US8349326B2 (en) * 2007-02-20 2013-01-08 Tufts University Methods and systems for multi-antibody therapies
US9023352B2 (en) * 2007-02-20 2015-05-05 Tufts University Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein
CA3035878C (fr) 2007-03-28 2023-01-03 REG Life Sciences, LLC Production amelioree de derives d'acides gras
WO2009009391A2 (fr) 2007-07-06 2009-01-15 Ls9, Inc. Systèmes et procédés pour la production d'esters gras
WO2009010826A2 (fr) 2007-07-13 2009-01-22 Ocean Nutrition Canada Ltd. Nouveaux gènes et procédés de production de caroténoïdes
WO2009036095A1 (fr) 2007-09-10 2009-03-19 Joule Biotechnologies, Inc. Organismes collecteurs de lumière synthétisés par génie génétique
WO2009042950A1 (fr) 2007-09-27 2009-04-02 Ls9, Inc. Diminution de l'effet toxique d'impuretés provenant de matières brutes par une fermentation extractive
CN101173214B (zh) 2007-10-30 2010-05-19 中国科学院南海海洋研究所 雨生红球藻的虾青素高产突变株
KR20090046376A (ko) 2007-11-06 2009-05-11 부경대학교 산학협력단 카로티노이드 생합성 유전자로 형질 전환된 효모 및 이를이용한 아스타잔틴의 대량 생산 방법
EP2327769B1 (fr) 2007-11-10 2013-03-27 Joule Unlimited Technologies, Inc. Organismes hyper-photosynthétiques
US8815567B2 (en) 2007-11-30 2014-08-26 E I Du Pont De Nemours And Company Coenzyme Q10 production in a recombinant oleaginous yeast
BRPI0821508B1 (pt) 2007-12-11 2018-12-26 Synthetic Genomics, Inc. cultura celular compreendendo uma cianobactéria recombinante da espécie synechococcus elongatus e método para converter carbono inorgânico em ácidos graxos.
US20090155864A1 (en) 2007-12-14 2009-06-18 Alan Joseph Bauer Systems, methods, and devices for employing solar energy to produce biofuels
ES2578522T3 (es) 2008-01-03 2016-07-27 Proterro, Inc Microorganismos fotosintéticos transgénicos y fotobiorreactor
TW200934872A (en) 2008-02-05 2009-08-16 Echem Hightech Co Ltd A strain of genetically reengineered escherichia coli for biosynthesis of high yield carotenoids after mutation screening
US8163516B2 (en) 2008-02-08 2012-04-24 Algenol Biofuels Inc. Selection of ADH in genetically modified cyanobacteria for the production of ethanol
BRPI0910286A2 (pt) 2008-03-03 2015-09-29 Abbott Lab métodos para transformação de levedura
US7981647B2 (en) 2008-03-03 2011-07-19 Joule Unlimited, Inc. Engineered CO2 fixing microorganisms producing carbon-based products of interest
JP2011522525A (ja) 2008-05-16 2011-08-04 エルエス９・インコーポレイテッド 炭化水素を製造するための方法および組成物
WO2010019813A2 (fr) 2008-08-13 2010-02-18 Sapphire Energy, Inc. Production d'acides gras par organismes photosynthétiques génétiquement modifiés
WO2010021711A1 (fr) 2008-08-18 2010-02-25 Ls9, Inc. Systèmes et procédés de production d'esters gras mixtes
EP2384366A4 (fr) 2008-09-05 2012-10-24 Jonathan Gressel Prévention de manière transgénique de l établissement et de la propagation d algues transgéniques dans des écosystèmes naturels
WO2010033921A2 (fr) 2008-09-19 2010-03-25 President And Fellows Of Harvard College Technologie de l’adipogenèse photo-autotrophique (phat)
US10407513B2 (en) 2008-09-26 2019-09-10 Ucb Biopharma Sprl Biological products
CA3038491A1 (fr) 2008-10-07 2010-04-15 REG Life Sciences, LLC Cellules hotes bacteriennes produites pour exprimer une reductase d'acide carboxylique et une thioesterase
US8394621B2 (en) 2008-10-23 2013-03-12 Matrix Genetrics, LLC Modified photosynthetic microorganisms for producing triglycerides
WO2010062480A2 (fr) 2008-10-28 2010-06-03 Ls9, Inc. Procédés et compositions pour la production d'alcools gras
WO2010062707A1 (fr) 2008-10-30 2010-06-03 Joule Unlimited, Inc. Procédés et compositions pour produire des produits d’intérêt à base de carbone dans des micro-organismes
KR20100051306A (ko) 2008-11-07 2010-05-17 부경대학교 산학협력단 파라코커스 해운댄시스의 돌연변이와 스트레스 처리에 의한아스타잔틴 생성량 증가 방법
AU2009330014A1 (en) 2008-12-23 2011-08-11 Matrix Genetics, Llc Modified photosynthetic microorganisms with reduced glycogen and their use in producing carbon-based products
EP3564345A1 (fr) 2008-12-23 2019-11-06 REG Life Sciences, LLC Procédés et compositions relatives à des enzymes thioestérases
WO2010078584A1 (fr) 2009-01-05 2010-07-08 Arizona Board Of Regents Cyanobactérie produisant des lipides neutres
EP2406378A4 (fr) 2009-03-11 2013-04-24 Sapphire Energy Inc Production de biocarburant dans des procaryotes et eucaryotes
WO2010118410A1 (fr) 2009-04-10 2010-10-14 Ls9, Inc. Production de dérivés d'acide gras
BRPI1015313B1 (pt) 2009-04-27 2021-06-01 Genomatica, Inc. Método fermentativo para produzir um éster de ácido graxo empregando um microorganismo geneticamente modificado e método para a produção de ésteres de ácidos graxos
CA2760326A1 (fr) 2009-05-13 2010-11-18 Basf Plant Science Company Gmbh Acyltransferases et leurs utilisations dans la production d'acide gras
EP2448955B1 (fr) 2009-06-29 2015-09-30 Synthetic Genomics, Inc. Gènes d'acyl-acp thiostérase et leurs utilisations
US8216815B2 (en) 2009-06-30 2012-07-10 Codexis, Inc. Production of fatty alcohols with fatty alcohol forming acyl-CoA reductases (FAR)
US7794969B1 (en) 2009-07-09 2010-09-14 Joule Unlimited, Inc. Methods and compositions for the recombinant biosynthesis of n-alkanes
WO2011011568A2 (fr) 2009-07-24 2011-01-27 The Regenst Of The University Of California Procédés et compositions pour la production d'acides gras chez des micro-organismes procaryotes photosynthétiques
WO2011018116A1 (fr) 2009-08-13 2011-02-17 Algenol Biofuels Inc. Cellules hôtes produisant de l'éthanol phototrophes améliorées du point de vue métabolique, procédé de production des cellules hôtes, produits de synthèse pour la transformation des cellules hôtes et procédé de production d'éthanol utilisant les cellules hôtes
US20120220007A1 (en) 2009-09-04 2012-08-30 President And Fellows Of Harvard College Production of secreted bioproducts from photosynthetic microbes
CN102656273B (zh) 2009-09-25 2016-05-25 Reg生命科学有限责任公司 脂肪酸衍生物的产生
JP5660543B2 (ja) 2009-10-27 2015-01-28 電源開発株式会社 新規細菌株、培養物及びカロテノイド色素の製造方法
WO2011059745A1 (fr) 2009-10-28 2011-05-19 The Arizona Board Of Regents For And On Behalf Of Arizona State University Bactérie pour la production d'acides gras
JP2013511261A (ja) 2009-11-18 2013-04-04 マリー ゴールバーン シーオー−オペレイティブ シーオー．リミテッド 組換え微生物
US8530221B2 (en) 2010-01-14 2013-09-10 Ls9, Inc. Production of branched chain fatty acids and derivatives thereof in recombinant microbial cells
WO2011127118A1 (fr) 2010-04-06 2011-10-13 Algenetix, Inc. Procédés de production d'huile dans des organismes non végétaux
US8980613B2 (en) 2010-04-06 2015-03-17 Matrix Genetics, Llc Modified photosynthetic microorganisms for producing lipids
WO2011127409A2 (fr) 2010-04-08 2011-10-13 Ls9, Inc. Procédés et compositions associés à des enzymes biosynthétiques d'alcools gras
GB201013041D0 (en) 2010-08-03 2010-09-15 Royal Holloway & New Bedford College Carotenoids
CL2011001984A1 (es) 2010-08-13 2012-06-29 Advanced Bionutrition Corp Composicion seca estabilizadora para material biologico que comprende carbohidrato, proteinas hidrolizadas de animal o de planta y un componente de acido carboxilico; metodo de preparacion; y formulacion de entrega oral que comprende la composicion seca estabilizadora.
WO2012033870A1 (fr) 2010-09-08 2012-03-15 The Penn State Research Foundation Phycobiliprotéines recombinantes présentant une fluorescence et des propriétés photochimiques accrues, et leurs méthodes de production et d'utilisation
CA2815888C (fr) 2010-10-25 2020-06-30 National Research Council Of Canada Anticorps specifiques de clostridium difficile et leurs applications
US20120115208A1 (en) 2010-10-26 2012-05-10 The Governors Of The University Of Alberta Modular method for rapid assembly of dna
EP2655592A2 (fr) 2010-12-20 2013-10-30 Matrix Genetics, LLC Microorganismes photosynthétiques modifiés pour produire des lipides
AU2011349444B2 (en) 2010-12-20 2016-06-30 Lumen Bioscience, Inc. Modified photosynthetic microorganisms for producing lipids
WO2012135668A1 (fr) 2011-03-31 2012-10-04 Exxonmobil Research And Engineering Company Ciblage des voies métaboliques par surexpression du facteur de transcription
WO2013048557A1 (fr) 2011-09-27 2013-04-04 Exxonmobil Research And Engineering Company Acyl-acp synthase d'ester cireux
WO2013116517A2 (fr) 2012-02-03 2013-08-08 Matrix Genetics, Llc Micro-organismes photosynthétiques modifiés pour la production continue de composés contenant du carbone
US8962299B2 (en) 2012-02-29 2015-02-24 Exxonmobil Research And Engineering Company Four-gene pathway for wax ester synthesis
AU2013230485A1 (en) 2012-03-09 2014-09-18 Matrix Genetics, Llc Modified diacylglycerol acyltransferase proteins and methods of use thereof
CN103382482A (zh) * 2012-05-03 2013-11-06 南开大学 一种食用安全性整合型螺旋藻高效表达载体及其应用技术
US9719122B2 (en) 2012-07-18 2017-08-01 Yeda Research And Development Co. Ltd. Methods of production of products of metabolic pathways
US9382554B2 (en) 2012-07-27 2016-07-05 Wisys Technology Foundation, Inc. Methods for isoprene and pinene production in cyanobacteria
MX2015005304A (es) 2012-10-24 2016-04-04 Nat Res Council Canada Anticuerpo contra campylobacter jejuni y usos para los mismos.
WO2014164232A1 (fr) 2013-03-13 2014-10-09 Matrix Genetics, Llc Cyanobactéries qui produisent des protéines d'empaquetage des lipides
AU2014249256A1 (en) 2013-03-13 2015-10-01 Lumen Bioscience, Inc. Cyanobacteria having improved photosynthetic activity
US9873907B2 (en) 2013-05-29 2018-01-23 Agilent Technologies, Inc. Method for fragmenting genomic DNA using CAS9
CN103820459B (zh) * 2014-01-22 2016-05-25 深圳大学 一种能预防禽流感的藻类饲料与应用
US10131870B2 (en) * 2014-09-09 2018-11-20 Lumen Bioscience, Inc. Targeted mutagenesis in Spirulina
AU2015317898A1 (en) 2014-09-15 2017-04-06 Lumen Bioscience, Inc. Cyanobacteria having improved photosynthetic activity
CN104311649B (zh) 2014-09-23 2018-01-09 中国科学院植物研究所 一种能提高植物光合效率的莱茵衣藻蛋白e6及其编码基因与应用
US20170240944A1 (en) 2014-10-14 2017-08-24 Matrix Genetics, Llc Modified Cyanobacteria for Producing Carotenoids
WO2016073562A1 (fr) * 2014-11-04 2016-05-12 Synthetic Biologics, Inc. Procédés et compositions pour l'inhibition de clostridium difficile
CN104479010A (zh) * 2014-12-20 2015-04-01 朱金凤 一种破壁螺旋藻蛋白粉的制备工艺
CN104480133A (zh) * 2015-01-06 2015-04-01 厦门大学 利用转座子介导外源基因导入螺旋藻的方法
CN107922463A (zh) 2015-04-24 2018-04-17 流明生物科学公司 具有提高的光合能力的微生物
AU2016294344A1 (en) 2015-07-10 2018-02-08 Lumen Bioscience, Inc. Microorganisms with broadened light absorption capability and increased photosynthetic activity
AU2016339975A1 (en) * 2015-10-13 2018-05-10 University Of Maryland, Baltimore Yeast-based immunotherapy against Clostridium difficile infection
WO2017139687A1 (fr) 2016-02-12 2017-08-17 Matrix Genetics, Llc Micro-organismes dotés de voies d'échappement à nadph pour réduire la photodégradation et stimuler la croissance dans des conditions de forte lumière
TWI591180B (zh) 2016-02-18 2017-07-11 基酵生物科技股份有限公司 提升耐熱性的植酸酶
WO2017208857A1 (fr) 2016-05-30 2017-12-07 ユニチカ株式会社 Procédé de production de polymère et dispositif de production
WO2019222711A1 (fr) * 2018-05-17 2019-11-21 Lumen Bioscience, Inc. Plate-forme d'administration de vaccin oral d'arthrospira platensis
US12252513B2 (en) 2018-07-16 2025-03-18 Lumen Bioscience, Inc. Thermostable phycobiliproteins produced from recombinant arthrospira
EP3994152A4 (fr) 2019-07-03 2023-08-02 Lumen Bioscience, Inc. Plate-forme d'administration non parentérale d'agent thérapeutique d'arthrospira platensis
CN112094342B (zh) 2020-09-25 2022-05-13 中国科学技术大学 与SARS-CoV-2 RBD结合的羊驼源纳米抗体
EP4267185A4 (fr) 2020-12-23 2024-10-30 Lumen Bioscience, Inc. Constructions comprenant des anticorps vhh à domaine unique dirigé contre le sars-cov-2
WO2022159819A1 (fr) 2021-01-22 2022-07-28 Lumen Bioscience, Inc. Expression et fabrication d'agents thérapeutiques protéiques dans la spiruline

Also Published As

Publication number Publication date
JP7770675B2 (ja) 2025-11-17
CN114341165A (zh) 2022-04-12
US20260109941A1 (en) 2026-04-23
WO2021003456A1 (fr) 2021-01-07
US12503682B2 (en) 2025-12-23
US20210338751A1 (en) 2021-11-04
AU2020298626A1 (en) 2022-02-24
CA3143735A1 (fr) 2021-01-07
JP2022539393A (ja) 2022-09-08
JP2025087768A (ja) 2025-06-10
EP3994152A1 (fr) 2022-05-11
IL289420A (en) 2022-02-01
EP3994152A4 (fr) 2023-08-02

Similar Documents

Publication Publication Date Title
EP3994152A4 (fr) Plate-forme d'administration non parentérale d'agent thérapeutique d'arthrospira platensis
EP4045480A4 (fr) Formulations pharmaceutiques
IL283840A (en) Compositions for the delivery of therapeutic agents and methods of use and making thereof
IL284733A (en) Pharmaceutical delivery compositions and uses thereof
MA51617A (fr) Mécanisme d'administration de médicament
EP3256149A4 (fr) Formulations pour administration orale d'agents actifs
EP3836866A4 (fr) Systèmes d'administration entérique d'agents thérapeutiques
EP3794017A4 (fr) Plate-forme d'administration de vaccin oral d'arthrospira platensis
MA49393A (fr) Poly(phosphoesters) destinés à l'administration d'acides nucléiques
EP3643353A4 (fr) Robot d'administration de médicament
MA55033A (fr) Formulation d'anticorps thérapeutique
IL285674A (en) Pharmaceutical formulations
IL282032A (en) Pharmaceutical compositions comprising rpl554 in hfa-134a for administration by inhalation
IL291601A (en) Neoglycoconjugates as vaccines and therapeutic tools
MA50047A (fr) Administration orale d'analogues peptidiques de glp-1
EP3773747A4 (fr) Utilisation d'exosomes pour l'administration ciblée d'agents thérapeutiques
EP4031520A4 (fr) Compositions d'imagerie et thérapeutiques
EP4203928A4 (fr) Agents thérapeutiques inhalables
EP3986415A4 (fr) Formulations d'ibogaïne
EP3773654C0 (fr) Compositions médicamenteuses polypharmaceutiques et méthodes associées
EP3525772A4 (fr) Formulations destinées à l'administration entérique d'agents thérapeutiques
EP3313380A4 (fr) Composition pour l'administration d'agents actifs à un animal
EP4021369A4 (fr) Dispositifs médicaux pour l'administration continue d'agents thérapeutiques
EP3746080A4 (fr) Formulations pharmaceutiques
EP3927328A4 (fr) Agent thérapeutique inhalable